Literature DB >> 1352943

PCNA expression in cutaneous keratinous neoplasms and verruca vulgaris.

N S Penneys1, M Bogaert, U Serfling, M Sisto.   

Abstract

Using an antibody to PCNA and a standard immunohistochemical system, the authors examined normal epidermis and cutaneous neoplasias for expression of PCNA, a protein associated with DNA polymerase delta and DNA replication. In squamous cell carcinoma in situ (SCCI), a unique expression of PCNA, which frequently involved the nuclei of all keratinocytes within the lesion, was found. Heaviest staining was in the uppermost layers of the epidermis. PCNA expression ended abruptly at the histologic margin of the lesion. Because SCCI can be associated with the presence of human papillomavirus (HPV) DNA, the authors evaluated PCNA expression in verruca vulgaris and found a pattern similar to that in SCCI. Assuming that PCNA expression in these two lesions is related to cell division, the authors hypothesize that the mechanisms that control proliferation in SCCI may be similar to those operative in verruca vulgaris.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352943      PMCID: PMC1886566     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  Autoantibody to a nuclear antigen in proliferating cells.

Authors:  K Miyachi; M J Fritzler; E M Tan
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

Review 2.  Mammalian DNA polymerases alpha and delta: current status in DNA replication.

Authors:  A G So; K M Downey
Journal:  Biochemistry       Date:  1988-06-28       Impact factor: 3.162

3.  DNA repair synthesis in human fibroblasts requires DNA polymerase delta.

Authors:  C Nishida; P Reinhard; S Linn
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

4.  Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.

Authors:  H Takahashi; G M Strutton; P G Parsons
Journal:  Histopathology       Date:  1991-03       Impact factor: 5.087

5.  Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation.

Authors:  R Bravo; S J Fey; J Bellatin; P M Larsen; J Arevalo; J E Celis
Journal:  Exp Cell Res       Date:  1981-12       Impact factor: 3.905

6.  Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis.

Authors:  R L Garcia; M D Coltrera; A M Gown
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

7.  Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

Authors:  P A Hall; D A Levison; A L Woods; C C Yu; D B Kellock; J A Watkins; D M Barnes; C E Gillett; R Camplejohn; R Dover
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

8.  Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle.

Authors:  P Kurki; M Vanderlaan; F Dolbeare; J Gray; E M Tan
Journal:  Exp Cell Res       Date:  1986-09       Impact factor: 3.905

9.  Individual nuclei in polykaryons can control cyclin distribution and DNA synthesis.

Authors:  J E Celis; A Celis
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

10.  Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites.

Authors:  R Bravo; H Macdonald-Bravo
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

View more
  4 in total

1.  Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.

Authors:  J Bujia; H Sudhoff; A Holly; H Hildmann; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently.

Authors:  A Hiraiwa; T Kiyono; S Suzuki; M Ohashi; M Ishibashi
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

3.  PCNA immunostaining combined with AgNOR staining in esophageal squamous cell carcinoma to identify patients with a poor prognosis.

Authors:  Y Morisaki; S Shima; Y Yoshizumi; Y Sugiura; S Tanaka; S Tamai
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

4.  Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol.

Authors:  Janet A Foote; James R Ranger-Moore; Janine G Einspahr; Kathylynn Saboda; Jaime Kenyon; James Warneke; Richard C Miller; Rayna Goldman; Min-Jian Xu; Denise J Roe; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.